 |
Finsbury is working media for Reckitt Benckiser Group’s record $1.4B opioid-linked settlement with the Justice Dept. and Federal Trade Commission regarding marketing practices for the Suboxone Film painkiller of its former subsidiary, Indivior.
Though UK-based RB maintains it did nothing wrong, the board opted to make peace with feds in the best interests of the company and shareholders.
The settlement “avoids the costs, uncertainty and distraction associated with continued investigations, litigation and the potential of an indictment at a time of significant transformation under RB 2.0 and during CEO transition,” said RB’s statement.
Laxman Narasimhan, who was chief commercial officer at PepsiCo, will succeed Rakesh Kapoor at the helm of the pharmaceuticals, personal care and “home hygiene” (Air Wick, Lysol, Calgon, Woolite, Vanish) company on Sept. 1.
RB “demerged” Indivior in 2014.
Finsbury’s Faeth Birch and Philip Walters rep RB.
Mike McNamara, the former US CEO of Dentons, has joined Baretz+Brunelle, which serves the legal economy, as its first CEO.
Publicis Health has agreed to shell out $350M to settle claims that its predatory and deceptive marketing for Purdue Pharma designed to increase sales of OxyContin helped fuel the opioid crisis, according to New York attorney general Letitia James.
Andrew Garson pled guilty in New York federal court on Nov. 1 to charges that he defrauded his former employers MWWPR and Catalyst PR of millions of dollars. He agreed to pay $3.8M in restitution and could be 
Chambers puts Reevemark, FGS Global, The Levinson Group, Trident DMG and Brunswick Group at the top of the heap for firms providing litigation PR and communications in its newly released rankings for 2023.
Gloria Labbad, partner and senior counsel at FGS Global, has joined Heather Podesta’s Invariant as it beefs up its litigation communications unit.
Have a comment? Send it to 
No comments have been submitted for this story yet.